This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TLC Taiwan Liposome (TLC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Taiwan Liposome Stock (NASDAQ:TLC) 30 days 90 days 365 days Advanced Chart Get Taiwan Liposome alerts:Sign Up Key Stats Today's Range$7.00▼$7.0950-Day Range$6.76▼$7.6352-Week Range$4.07▼$7.70Volume12,421 shsAverage Volume133,095 shsMarket Capitalization$294.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. Read More Receive TLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Taiwan Liposome and its competitors with MarketBeat's FREE daily newsletter. Email Address TLC Stock News HeadlinesThe True and Tragic Story of TLC’s Lisa ‘Left Eye’ LopesJuly 4, 2025 | yahoo.com‘90 Day Fiancé: Happily Ever After?’ Season 9 Cast Photos: Meet The 8 Couples Returning To TLC SeriesJuly 4, 2025 | msn.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. | Brownstone Research (Ad)TLC Recovery House celebrating 4th Anniversary and Recovery RallyJuly 4, 2025 | msn.comAdult virgins break taboos and take huge emotional risks in tonight’s must-see TLC episodeJuly 1, 2025 | msn.comPhiladelphia Leadership: Emily Gatto, Director, TLC WellnessJune 26, 2025 | msn.comHow to watch ‘Match Me Abroad’ Season 2 TLC dating show free or on demandJune 23, 2025 | msn.comTLC’s hit show ‘Match Me Abroad’ returns after 2-year break: How you can watch the new season freeJune 23, 2025 | msn.comSee More Headlines TLC Stock Analysis - Frequently Asked Questions How were Taiwan Liposome's earnings last quarter? Taiwan Liposome Company, Ltd. (NASDAQ:TLC) announced its quarterly earnings data on Wednesday, October, 28th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $2.28 million for the quarter, compared to analyst estimates of $0.38 million. Taiwan Liposome had a negative net margin of 299.27% and a negative trailing twelve-month return on equity of 120.45%. When did Taiwan Liposome IPO? Taiwan Liposome (TLC) raised $29 million in an initial public offering (IPO) on the week of November 19th 2018. The company issued 5,000,000 shares at a price of $5.80 per share. Cantor acted as the underwriter for the IPO and CLSA, H.C. Wainwright, Janney Montgomery Scott and Laidlaw & Company (UK) Ltd. were co-managers. What other stocks do shareholders of Taiwan Liposome own? Based on aggregate information from My MarketBeat watchlists, some other companies that Taiwan Liposome investors own include Avino Silver & Gold Mines (ASM), Trevena (TRVN), Bionano Genomics (BNGO), Pfizer (PFE), Wells Fargo & Company (WFC), Aadi Bioscience (AADI) and BioLineRx (BLRX). Company Calendar Last Earnings10/28/2020Today7/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:TLC CIK1722890 Webwww.tlcbio.com Phone886226557377FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.02 million Net Margins-299.27% Pretax Margin-306.10% Return on Equity-120.45% Return on Assets-55.11% Debt Debt-to-Equity Ratio0.67 Current Ratio3.01 Quick Ratio3.01 Sales & Book Value Annual Sales$3.63 million Price / Sales81.14 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book8.43Miscellaneous Outstanding Shares42,077,000Free FloatN/AMarket Cap$294.54 million OptionableNot Optionable Beta0.99 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:TLC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taiwan Liposome Company, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taiwan Liposome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLC Stock Alerts